BioGaia AB (publ)
BIOGYOTCHealthcare● Active
$11.00
+$0.00(+0.00%)
Market Cap$1.1B
P/E Ratio—
52W High$11.46
52W Low$8.79
BioGaia AB (publ) (BIOGY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BIOGY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.08
Revenue
$0.04B
Est. $0.04B · +5.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat Revenue
BIOGY reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q2 FY2026 | May 5, 2026 | — | $0.08 | — | $0.04B | $0.04B | +5.5% |
| — Q1 FY2026 | Feb 10, 2026 | — | $0.11 | — | $0.05B | $0.04B | +12.1% |
| — Q4 FY2025 | Oct 20, 2025 | — | $0.07 | — | $0.03B | — | — |
| — Q3 FY2025 | Jul 18, 2025 | — | $0.09 | — | $0.04B | $0.34B | -87.7% |
| — Q2 FY2025 | May 7, 2025 | — | $0.79 | — | $0.37B | — | — |
| — Q1 FY2025 | Feb 12, 2025 | — | $0.81 | — | $0.36B | — | — |
| — Q4 FY2024 | Oct 22, 2024 | — | $0.36 | — | $0.30B | — | — |
| — Q3 FY2024 | Jul 23, 2024 | — | $1.10 | — | $0.38B | — | — |
Q2 FY2026
May 5, 2026
EPS Actual
$0.08
EPS Est.
—
EPS Surpr.
—
Revenue
$0.04B
Q1 FY2026
Feb 10, 2026
EPS Actual
$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.05B
Q4 FY2025
Oct 20, 2025
EPS Actual
$0.07
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q3 FY2025
Jul 18, 2025
EPS Actual
$0.09
EPS Est.
—
EPS Surpr.
—
Revenue
$0.04B
Q2 FY2025
May 7, 2025
EPS Actual
$0.79
EPS Est.
—
EPS Surpr.
—
Revenue
$0.37B
Q1 FY2025
Feb 12, 2025
EPS Actual
$0.81
EPS Est.
—
EPS Surpr.
—
Revenue
$0.36B
Q4 FY2024
Oct 22, 2024
EPS Actual
$0.36
EPS Est.
—
EPS Surpr.
—
Revenue
$0.30B
Q3 FY2024
Jul 23, 2024
EPS Actual
$1.10
EPS Est.
—
EPS Surpr.
—
Revenue
$0.38B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2026 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.4B | $0.4B | $0.4B | 1 |
| Q2 FY2026 | $0.5B | $0.5B | $0.5B | 1 |
| Q1 FY2026 | $0.4B | $0.4B | $0.4B | 1 |
| Q4 FY2025 | $0.4B | $0.4B | $0.4B | 1 |
| Q3 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2025 | $0.4B | $0.4B | $0.4B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 5, 2026 | — | $11.00 | $11.00 | +0.00% |
| — Q1 FY2026 | Feb 10, 2026 | — | $11.00 | $11.00 | +0.00% |
| — Q4 FY2025 | Oct 20, 2025 | — | $11.25 | $11.25 | +0.00% |
| — Q3 FY2025 | Jul 18, 2025 | — | $9.75 | $9.75 | +0.00% |
| — Q2 FY2025 | May 7, 2025 | — | $10.81 | $10.81 | +0.00% |
| — Q1 FY2025 | Feb 12, 2025 | — | $9.35 | $9.35 | +0.00% |
| — Q4 FY2024 | Oct 22, 2024 | — | $11.50 | $11.50 | +0.00% |
| — Q3 FY2024 | Jul 23, 2024 | — | $11.50 | $11.00 | -4.35% |
Q2 FY2026+0.00%
Report Date
May 5, 2026
EPS Beat/Miss
—
Price Before
$11.00
Price After
$11.00
Q1 FY2026+0.00%
Report Date
Feb 10, 2026
EPS Beat/Miss
—
Price Before
$11.00
Price After
$11.00
Q4 FY2025+0.00%
Report Date
Oct 20, 2025
EPS Beat/Miss
—
Price Before
$11.25
Price After
$11.25
Q3 FY2025+0.00%
Report Date
Jul 18, 2025
EPS Beat/Miss
—
Price Before
$9.75
Price After
$9.75
Q2 FY2025+0.00%
Report Date
May 7, 2025
EPS Beat/Miss
—
Price Before
$10.81
Price After
$10.81
Q1 FY2025+0.00%
Report Date
Feb 12, 2025
EPS Beat/Miss
—
Price Before
$9.35
Price After
$9.35
Q4 FY2024+0.00%
Report Date
Oct 22, 2024
EPS Beat/Miss
—
Price Before
$11.50
Price After
$11.50
Q3 FY2024-4.35%
Report Date
Jul 23, 2024
EPS Beat/Miss
—
Price Before
$11.50
Price After
$11.00
Beat Rate0 / 8 quarters
Largest Move-4.35% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BIOGY ends December
BioGaia AB (publ) (BIOGY) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.08 (in line with the analyst consensus of —). The next BIOGY earnings date is expected around September 1, 2026.
Each quarter, investors track BIOGY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIOGY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BIOGY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BIOGY earnings · 4 questionsBioGaia AB (publ)'s next earnings report is expected around September 1, 2026. BIOGY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIOGY historically reports after market close (AMC).
BIOGY earnings datewhen is BIOGY earningsBIOGY next earnings datewhen does BIOGY report earningsBIOGY earnings calendar
▸ Source: FMP · BioGaia AB (publ) SEC filings · US GAAP · BioGaia AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026